Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

162 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

NCT04225715

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Tokuda Hospital Sofia Sofia, Bulgaria
  • University Multiprofile Hospital For Active Treatment "Sveti Ivan Rilski" EAD Sofia, Bulgaria
  • University of Calgary Calgary, Alberta, Canada
  • Uni of Alberta Hospital Edmonton, Alberta, Canada
View all 33 locations
View Trial Details
Completed

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

NCT04439539

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Ruane Clinical Research Group Inc Los Angeles, California, United States
  • UPMC Center For Liver Diseases Pittsburgh, Pennsylvania, United States
  • Liver Institute Northwest Seattle, Washington, United States
  • University of Calgary Calgary, Alberta, Canada
View all 47 locations
View Trial Details
Completed

A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection

NCT05123599

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • UZ Antwerpen Edegem, Belgium
  • UZA-SGS Edegem, Belgium
  • Hopital Beaujon Clichy, France
  • Hopital de La Croix Rousse Lyon, France
View all 13 locations
View Trial Details
Completed

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants

NCT05275023

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Toronto General Hospital Toronto, Ontario, Canada
  • Fakultni nemocnice Hradec Kralove Hradec Králové, Czechia
  • IKEM Prague, Czechia
  • Hopital Beaujon Clichy, France
View all 26 locations
View Trial Details
Completed

A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

NCT04129554

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Cliniques Universitaires Saint Luc Brussels, Belgium
  • SGS Belgium NV Edegem, Belgium
  • UZ Antwerpen Edegem, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
View all 41 locations
View Trial Details
Completed

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

NCT03982186

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • The Office of Franco Felizarta, MD Bakersfield, California, United States
  • Ruane Clinical Research Group Inc Los Angeles, California, United States
  • Southern California GI and Liver Center San Clemente, California, United States
  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 108 locations
View Trial Details
Completed

A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B

NCT04426968

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • The fifth medical center of PLA Beijing, Beijing Municipality, China
  • Jilin Hepatobiliary Disease Hospital Changchun, China
  • The first hospital of Jilin University Changchun, China
  • Chizhou People's Hospital Chizhou, China
View Trial Details

Related conditions